Cargando…
Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients
Background. The peritoneal surface is an acknowledged locoregional failure site of abdominal malignancies. Previous treatment attempts with medical therapy alone did not result in long-term survival. During the last two decades, new treatment protocols combining cytoreductive surgery with perioperat...
Autores principales: | Van der Speeten, K., Govaerts, K., Stuart, O. A., Sugarbaker, P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384921/ https://www.ncbi.nlm.nih.gov/pubmed/22778722 http://dx.doi.org/10.1155/2012/378064 |
Ejemplares similares
-
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006) -
Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011) -
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
por: Van der Speeten, Kurt, et al.
Publicado: (2009) -
Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization
por: Lemoine, Lieselotte, et al.
Publicado: (2019) -
2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)